Linked Life Data

16537662

Source:http://linkedlifedata.com/resource/pubmed/id/16537662

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2006-4-20
pubmed:databankReference
pubmed:abstractText
Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2006 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
354
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1685-97
pubmed:dateRevised
2007-9-26
pubmed:meshHeading
pubmed-meshheading:16537662-Adult, pubmed-meshheading:16537662-Aged, pubmed-meshheading:16537662-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:16537662-Antihypertensive Agents, pubmed-meshheading:16537662-Benzimidazoles, pubmed-meshheading:16537662-Biphenyl Compounds, pubmed-meshheading:16537662-Blood Pressure, pubmed-meshheading:16537662-Double-Blind Method, pubmed-meshheading:16537662-Dyslipidemias, pubmed-meshheading:16537662-Feasibility Studies, pubmed-meshheading:16537662-Female, pubmed-meshheading:16537662-Humans, pubmed-meshheading:16537662-Hypertension, pubmed-meshheading:16537662-Incidence, pubmed-meshheading:16537662-Logistic Models, pubmed-meshheading:16537662-Male, pubmed-meshheading:16537662-Middle Aged, pubmed-meshheading:16537662-Obesity, pubmed-meshheading:16537662-Tetrazoles
pubmed:year
2006
pubmed:articleTitle
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
pubmed:affiliation
University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, Ann Arbor, MI 48106, USA. sjulius@umich.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study